Skip to main content

Market Overview

Buy Thermo Fisher On Amazon Fear-Inspired Dip

Share:
Buy Thermo Fisher On Amazon Fear-Inspired Dip

Shares of Thermo Fisher Scientific Inc. (NYSE: TMO) came under heavy selling pressure last Friday, which continued into Monday's trading session amid ongoing concerns that Amazon.com, Inc. (NASDAQ: AMZN) is looking to enter lab supplies and other health care related businesses. But Thermo Fisher's shareholders shouldn't be concerned, at least according to Leerink's Puneet Souda who maintains an Outperform rating on Thermo Fisher's stock and recommends investors buy shares on the dip.

Thermo Fisher's "unmatched scale" will certainly pose a challenge for Amazon should it enter the space, the analyst wrote (see Souda's track record here). But it is unlikely in the first place Amazon will try to take over Thermo Fisher's market, as this has been an ongoing on-and-off rumor for the past six years.

In fact, it would be challenging for Amazon to try and take over the channel for four reasons, including:

    1. Lab supplies is a very small market at $15 billion as opposed to a $300 to $400 billion PBM market Amazon may find more lucrative.
    2. TMO's stickiness would be very hard for anyone to break.
    3. Low-value purchase orders are streamlined to Thermo Fisher in a way that Amazon may not be able to replicate.
    4. Thermo Fisher deals with complex products that require large sales and support teams.

Finally, it is difficult to imagine a scenario where Amazon supplies restriction enzymes, proteases, QPCRs, sequencing supplies, Nanodrops and LC-MS products.

"We believe AMZN is fully capable of supplying orders of IT hardware and has taken share from CDW-G (the government/academic IT hardware provider) among universities and government accounts, but same cannot be said for Fisher's catalog (Catalog LINK) just yet," the analyst also stated.

Related Links:

Why Amazon Needs To Partner With Or Buy A Pharmacy Benefit Manager

Analyst: Amazon's Entry Into Pharmacy Is All But Certain At This Point
_________
Image Credit: Coolcaesar at en.wikipedia [CC BY-SA 3.0 (https://creativecommons.org/licenses/by-sa/3.0) or GFDL (http://www.gnu.org/copyleft/fdl.html)], via Wikimedia Commons

Latest Ratings for AMZN

DateFirmActionFromTo
Apr 2021Credit SuisseMaintainsOutperform
Apr 2021Evercore ISI GroupAssumesOutperform
Feb 2021CitigroupMaintainsBuy

View More Analyst Ratings for AMZN
View the Latest Analyst Ratings

 

Related Articles (AMZN + TMO)

View Comments and Join the Discussion!

Posted-In: health careAnalyst Color Long Ideas Health Care Reiteration Analyst Ratings Trading Ideas General Best of Benzinga

Latest Ratings

StockFirmActionPT
SAMEvercore ISI GroupMaintains1,500.0
SEAutonomous ResearchInitiates Coverage On378.0
ALHCMorgan StanleyInitiates Coverage On36.0
ALHCRaymond JamesInitiates Coverage On30.0
HAEMorgan StanleyDowngrades83.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com